| Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide (NCT05260112) | University of Pennsylvania | 2021-11-05 |
| Interstitial Cystitis: Monitoring of the Psychic State and Counseling Intervention in the COVID-19 Era (NCT05752344) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2020-11-01 |
| Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome (NCT04275297) | Vanderbilt University Medical Center | 2020-07-13 |
| Bladder Directed vs. Pelvic Floor Therapy in IC/BPS (NCT02870738) | Corewell Health East | 2017-04-21 |
| Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain (NCT02781103) | Kenneth M Peters, MD | 2017-01-20 |
| A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome (NCT02868775) | Philadelphia Urosurgical Associates | 2016-09-01 |
| A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis (NCT02787083) | Philadelphia Urosurgical Associates | 2016-08-01 |
| Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis (NCT02497976) | ICStudy, LLC | 2015-12-15 |
| A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome (NCT02411110) | Allergan | 2015-05-21 |
| A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions (NCT02395042) | Allergan | 2015-04-15 |
| Chronic Pain Risk Associated With Menstrual Period Pain (NCT02214550) | Endeavor Health | 2014-07-01 |
| A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC) (NCT01613586) | Astellas Pharma Europe B.V. | 2012-05-31 |
| The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction (NCT01482676) | Insel Gruppe AG, University Hospital Bern | 2010-10-01 |
| A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain (NCT01060254) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-04-06 |
| A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome (NCT00999518) | Pfizer | 2010-01-22 |
| DMSO Efficacy in IC/PBS Patients During and After Treatment (NCT01074567) | Assaf-Harofeh Medical Center | 2009-12-01 |
| Treatment of Interstitial Cystitis/Painful Bladder Syndrome Using Alternative Techniques: Exercise, Meditation, Tai Chi (NCT00661050) | Stanford University | 2008-04-01 |
| An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis (NCT00601484) | Pfizer | 2008-03-17 |
| Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC. (NCT00775281) | Insel Gruppe AG, University Hospital Bern | 2006-10-01 |
| Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis (NCT00380783) | Allergan | 2006-10-01 |
| Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis (NCT00275379) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-08-01 |
| Events Preceding Interstitial Cystitis (EPIC) (NCT00248664) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2004-03-01 |
| Diagnostic Challenges in IC (and Male CPPS) (NCT00672087) | Beth Israel Deaconess Medical Center | 2003-09-01 |